Price | 7500€+ Login to see price |
Organism | Human |
Product Type | Organoid + T cell + Regulatory T cell |
Tissue | Adaptive |
Disease | – |
Applications
Cancer Organoid
Colorectal Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Breast Cancer
Cholangiocarcinoma
Gastric Cancer
Ovarian Cancer
With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have...
Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without...
Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but...
We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of...
A drug evaluation solution co-culturing Treg, T cells, and cancer organoids allows for the assessment of drugs that can regulate Treg. This provides a drug evaluation solution capable of evaluating drugs that can modulate Treg.
We aimed to develop tumor organoids with a tumor microenvironment and use them as a solution for drug evaluation.
For this, we created a system where tumor organoids, cytotoxic T cells, and regulatory T cells were co-cultured at specific ratios.
We activated T cells from PBMCs, then separately cultured and counted cytotoxic T cells and regulatory T cells.
Finally, after establishing the co-culture system at designated ratios, we measured the efficacy of immuno-oncology drugs.
R1 / T-cell
R1 / T-cell
Cell nr | Gated % | |
|---|---|---|
CD8+ | 47,600 | – |
All Events / Treg
CD4+CD5+ / Treg
Cell nr | Gated % | |
|---|---|---|
CD8+ CD25+ FoxP3 | 7,500 | – |
Deutscher Platz 5c, 04103, Leipzig, Germany
info@lambdabiologics.com
